IGWM
NVCR icon

ICA Group Wealth Management’s NovoCure NVCR Stock Holding History

ICA Group Wealth Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$1.71K Hold
100
– – ﹤0.01% 702
2024
Q1 		$1.56K Hold
100
– – ﹤0.01% 1202
2023
Q4 		$1.49K Buy
+100
New +$1.34K ﹤0.01% 1204
2023
Q3 		– Sell
-100
Closed -$4.15K – 869
2023
Q2 		$4.15K Hold
100
– – ﹤0.01% 1016
2023
Q1 		$6.01K Hold
100
– – ﹤0.01% 906
2022
Q4 		$7.33K Buy
+100
New +$7.52K ﹤0.01% 886

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

ICA Group Wealth Management's NVCR Position: Q2 2024 in Review

ICA Group Wealth Management held its NovoCure (NVCR) position steady in Q2 2024 at 100 shares worth $1.71K. The position accounts for ﹤0.01% of the portfolio, ranked #702.

ICA Group Wealth Management first reported a position in NVCR in Q4 2022 and has held it in 6 quarters since. The position peaked at $7.33K in Q4 2022. 236 funds tracked by Wall St. Rank hold NVCR as of Q2 2024.

  • ICA Group Wealth Management held 100 shares of NovoCure worth $1.71K as of Q2 2024.
  • ICA Group Wealth Management left its NovoCure share count unchanged in Q2 2024.
  • NovoCure made up ﹤0.01% of ICA Group Wealth Management's portfolio in Q2 2024, its #702 holding.
  • ICA Group Wealth Management first reported a position in NovoCure in Q4 2022 and has held it in 6 quarters since.
  • ICA Group Wealth Management's NovoCure position peaked at $7.33K in Q4 2022.
  • 236 funds tracked by Wall St. Rank held NovoCure as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.